Proteomic profiling of the epithelial-mesenchymal transition using 2D DIGE

Methods in Molecular Biology

Volumn 854, Issue , 2012, Pages 269-286

  Mathias, Rommel A ^a   Ji, Hong ^a   Simpson, Richard J ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

DIGE; EMT; Epithelial mesenchymal transition; MDCK; Quantitative proteomics; Ras; Secretome

Indexed keywords

PROTEIN P21; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; CELL LINE; DOG; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IMAGE PROCESSING; ISOELECTRIC FOCUSING; METABOLISM; METHODOLOGY; PROTEOMICS; REPRODUCIBILITY; STAINING; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ANIMALS; CELL LINE; DOGS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOELECTRIC FOCUSING; PROTEOMICS; PROTO-ONCOGENE PROTEINS P21(RAS); REPRODUCIBILITY OF RESULTS; STAINING AND LABELING; TRANSFORMING GROWTH FACTOR BETA; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84858146882     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-573-2_19     Document Type: Article

References (39)

1. Weigelt B, Peterse JL, and van't Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5 :591-602
2. Chen EI, and Yates JR, 3rd (2007) Cancer proteomics by quantitative shotgun proteomics. Mol Oncol 1 :144-159
3. Chambers AF, Groom AC, and MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2 :563-572
4. Woodhouse EC, Chuaqui RF, and Liotta LA (1997) General mechanisms of metastasis. Cancer 80 :1529-1537
5. Eccles SA, and Welch DR (2007) Metastasis: recent discoveries and novel treatment strategies. Lancet 369 :1742-1757
6. Gupta GP, and Massague J (2006) Cancer metastasis: building a framework. Cell 127 :679-695
7. Christofori G (2006) New signals from the invasive front. Nature 441 :444-450
8. Geiger TR, and Peeper DS (2009) Metastasis mechanisms. Biochim Biophys Acta 1796 :293-308
9. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nature Reviews: Cancer 2 :442-454
10. Bonnomet A, Brysse A, Tachsidis A, Waltham M et al (2010) Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia 15 :261-273
11. Berx G, Raspe E, Christofori G, Thiery JP et al (2007) Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin Exp Metastasis 24 :587-597
12. Hay ED (1995) An overview of epitheliomesenchymal transformation. Acta Anat (Basel) 154 :8-20
13. Thiery JP, and Chopin D (1999) Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev 18 :31-42
14. Perl AK, Wilgenbus P, Dahl U, Semb H et al (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392 :190-193
15. Mathias RA, Chen YS, Wang B, Ji H et al (2010) Extracellular remodelling during oncogenic Ras-induced epithelial-mesenchymal transition facilitates MDCK cell migration. J Proteome Res 9 :1007-1019
16. Sabbah M, Emami S, Redeuilh G, Julien S et al (2008) Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updates 11 :123-151
17. Chen YS, Mathias RA, Mathivanan S, Kapp EA et al (2010) Proteomic profi ling of MDCK plasma membranes reveals Wnt-5a involvement during oncogenic H-Ras/TGF-{beta}- mediated epithelial-mesenchymal transition. Mol Cell Proteomics
18. Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A et al (2008) The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 68 :537-544
19. Vandewalle C, Comijn J, De Craene B, Vermassen P et al (2005) SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res 33 :6566-6578
20. Zhang X, Wei D, Yap Y, Li L et al (2007) Mass spectrometry-based "omics" technologies in cancer diagnostics. Mass Spectrom Rev 26 :403-431
21. Walther TC, and Mann M (2010) Mass spectrometry- based proteomics in cell biology. J Cell Biol 190 :491-500
22. Jechlinger M, Grunert S, Tamir IH, Janda E et al (2003) Expression profi ling of epithelial plasticity in tumor progression. Oncogene 22 :7155-7169
23. Yang J, Mani SA, Donaher JL, Ramaswamy S et al (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117 :927-939
24. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136 :215-233
25. Gregory PA, Bracken CP, Bert AG, and Goodall GJ (2008) MicroRNAs as regulators of epithelial- mesenchymal transition. Cell Cycle 7 :3112-3118
26. Mathias RA, and Simpson RJ (2009) Towards understanding epithelial-mesenchymal transition: a proteomics perspective. Biochim Biophys Acta 1794 :1325-1331
27. Wei J, Xu G, Wu M, Zhang Y et al (2008) Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. Anticancer Res 28 :327-334
28. Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, Woelfl e U et al (2005) Changes in cytoskeletal protein composition indicative of an epithelial- mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 11 :8006-8014
29. Wu L, and Han DK (2006) Overcoming the dynamic range problem in mass spectrometrybased shotgun proteomics. Expert Rev Proteomics 3 :611-619
30. Alban A, David SO, Bjorkesten L, Andersson C et al (2003) A novel experimental design for comparative two-dimensional gel analysis: twodimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3 :36-44
31. Unlu M, Morgan ME, and Minden JS (1997) Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18 :2071-2077
32. Timms JF, and Cramer R (2008) Difference gel electrophoresis. Proteomics 8 :4886-4897
33. Friedman DB, and Lilley KS (2008) Optimizing the difference gel electrophoresis (DIGE) technology. Methods Mol Biol 428 :93-124
34. Minden J (2007) Comparative proteomics and difference gel electrophoresis. BioTechniques 43 :739, 741, 743 passim
35. Van den Bergh G, and Arckens L (2004) Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gelbased proteomics. Curr Opin Biotechnol 15 :38-43
36. Mathias RA, Wang B, Ji H, Kapp EA et al (2009) Secretome-Based Proteomic Profiling of Ras-Transformed MDCK Cells Reveals Extracellular Modulators of Epithelial-Mesenchymal Transition. J Proteome Res 8 :2827-2837
37. Simpson RJ, Connolly LM, Eddes JS, Pereira JJ et al (2000) Proteomic analysis of the human colon carcinoma cell line (LIM 1215): development of a membrane protein database. Electrophoresis 21 :1707-1732
38. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 :55-63
39. Phillips HJ, and Terryberry JE (1957) Counting actively metabolizing tissue cultured cells. Exp Cell Res 13 :341-347